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OBJECTIVE: It has been well established that the long-term prognosis of intrahepatic duct stones (IHDS)
is complicated by the late development of biliary cirrhosis with associated intrahepatic cholangiocarci-
noma (IHCC). Despite recent improvements in imaging studies, accurate preoperative diagnosis of IHCC
is difficult. Therefore, we attempted to elucidate the clinical features of patients with IHDS with IHCC.
METHODS: We reviewed 80 patients with IHDS and divided them into two groups. The DS group
included 72 patients who had only IHDS. The second group was defined as the CC group and included
eight patients who had IHDS and IHCC. For diagnosis of IHDS and confirmation of coexisting IHCC,
patients underwent various radiological evaluations and additional laboratory tests, such as serum 
carbohydrate antigen 19-9 (CA 19-9).
RESULTS: There was no significant difference in the symptoms and stone characteristics between the
two groups. For the CC group, liver resection was performed in four patients. Three patients underwent
curative resection, but only one of these patients was alive at 36 months without recurrence.
CONCLUSION: IHCC with IHDS was difficult to diagnose in the early phase. Therefore, while perform-
ing diagnostic studies and surgery for IHDS, one should always consider the possibility of coexisting
cholangiocarcinoma. [Asian J Surg 2009;32(1):7–12]
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Introduction
Intrahepatic duct stones (IHDS) have a higher prevalence
in Asian countries compared to other regions of the world.
Although many physicians have made an effort to effec-
tively manage patients diagnosed with IHDS, the possibil-
ity of the development of biliary cirrhosis or intrahepatic
cholangiocarcinoma (IHCC) has led to a poor prognosis
for these patients.1 The possibility of the development of
IHCC has been more extensively investigated because it
has been reported that the effect of treatment for IHCC is
very unsatisfactory. The first two cases of IHCC occurring
together with IHDS were reported in 1942.2 Recent reports
have documented that the rate of the development of IHCC
while patients are being treated and followed for IHDS was
4 to 11%.3–5 Because this potential for the development of
IHCC is not trivial and the diagnosis is difficult, it is
important that clinicians know about the various charac-
ters of IHCC associated with IHDS. The aim of this study
was to describe the clinical features of IHCC that devel-
oped in patients who were diagnosed with IHDS and to
provide an aid to assess presence of characteristic features
for an early diagnosis of IHCC in patients with IHDS.
Patients and methods
Between 1993 and 2004, we treated 80 patients with
IHDS at the Holy Family Hospital, Bucheon-City, Korea
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with a mean follow-up of 35 months. We divided the 
80 patients into two groups. The DS group included 72
patients who had been treated for IHDS without IHCC.
The CC group included eight patients who were diag-
nosed with IHCC at the same time or during a follow-up
period after they had been treated for IHDS. We com-
pared the two groups with regard to clinical features such
as: gender, age, previous treatment, radiologic evaluation,
and symptoms. We retrospectively examined the charac-
teristics of the stones and treatment methods in both
groups. We evaluated the results of a tumour marker 
(CA 19-9) and other laboratory studies, radiological and
surgical findings, and the outcome for both groups.
A Mann-Whitney U test for continuous variables and
Fisher’s exact test for categorical variables were used 
for comparison of the study groups. A value of p < 0.05
(two-sided) was considered to be significant.
Results
Patient characteristics and symptoms
We compared the two groups with regard to the clinical
characteristics: age, gender, and previous biliary surgery.
The results are summarised in Table 1. There is no differ-
ence between the two groups in any of the characteristics,
and the number of female patients was three times greater
than the number of male patients in both groups. In both
groups, the most common previous biliary surgery was
cholecystectomy.
The patients presented with abdominal pain, fever and
jaundice as initial symptoms. Abdominal pain was the
most common symptom and was found in over 90% of
patients in both groups. Jaundice occurred in only 33% 
of the DS group and 38% of the CC group. There was no
significant difference in the symptoms between the two
groups (Table 2).
Diagnosis and characteristics of IHDS in the two groups
The diagnosis of intrahepatic duct stones was not difficult
in patients where this was highly suspected. Abdominal
ultrasonography (US) and computed tomography (CT)
were commonly used for the detection of the stones and
to identify their location in both groups. Endoscopic ret-
rograde cholangiopancreaticogram (ERCP) or magnetic
resonance cholangiopancreaticogram (MRCP) was per-
formed when necessary to confirm clinical suspicion or to
identify causes of obstruction (Table 2).
CA 19-9 level at the diagnostic time was retrospectively
evaluated in the 21 patients, and the variance was too
large to analyse the difference between the two groups. In
the DS group, the range of CA 19-9 levels of 17 evaluated
patients was 1.33 to 10,942 U/mL. The range of four
patients in the CC group was 460 U/mL to 4,438 U/mL.
No difference in the results between the two groups was
shown in other laboratory findings such as AST, ALT, and
total bilirubin.
The most common site for the stones was in the left
liver (51 cases of 80 patients, 64%). There was no signifi-
cant difference in the incidence of IHCC on the basis 
of the location of the stones (Table 3). Out of a total of 
80 patients, 68 patients (85%) had pigment stones. All
patients in the CC group had pigmented stones, but there
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Table 1. Patient characteristics in the DS and CC groups
Characteristics†
DS group CC group
p*
(n=72) (n=8)
Age (yr)† 56.6 (29–82) 60.0 (37–83) 0.407
Male:Female 20:52 2:6 1.000
Previous biliary 32 (44%)‡ 2 (25%)§ 0.457
surgery (%)
*Statistical significance was tested by the Mann-Whitney U test for
continuous variables and Fisher’s exact test for categorical variables;
†presented as median (range); ‡the most common previous biliary
operation in the DS group was cholecystectomy (25 cases; 78%); 
§two prior biliary operations in the CC group were cholecystectomies.
Table 2. Symptoms and radiologic evaluations for patients in
both groups
DS group CC group
p*
(n=72) (n=8)
Symptoms
Abdominal pain 66 (92%) 8 (100%) 1.000
Fever 20 (28%) 3 (38%) 0.683
Jaundice 24 (33%) 3 (38%) 1.000
No symptoms 2 (3%) 0 (0%) 1.000
Radiologic methods
US 52 (72%) 7 (88%) 0.674
ERCP 15 (21%) 2 (25%) 0.676
MRCP 15 (21%) 0 (0%) 0.341
CT 29 (40%) 5 (63%) 0.275
*Statistical significance was tested by Fisher’s exact test. US =
abdominal ultrasonography; ERCP = endoscopic retrograde cholan-
giopancreaticogram; MRCP = magnetic resonance cholangiopancre-
aticogram; CT = computed tomography.
was also no significant difference in stone type between
the two groups.
Treatment methods used for patients in the DS group
Table 4 shows the treatment methods used for the DS
group. Surgical intervention could not be provided in 10
patients, due to patient refusal or high surgical risk. The
surgical methods used for the patients in the DS group
differed according to the stone location and the status of
the liver parenchyma. We performed hepatectomy for
cases with severe atrophic liver parenchyma, possible
malignancy, or main hepatic duct stricture. The most com-
mon operation for a left IHDS was left lateral sectionec-
tomy (55%). However, in cases of a right IHDS or IHDS on
both sides, choledochoscopic removal was used most
commonly. Right hepatectomy was performed in only one
patient, because of the high risk of operative mortality
and morbidity. After treatment for IHDS, patients had 
a mean follow-up of 37 months without development of
cholangiocarcinoma.
Clinical characteristics of patients in the CC group
We evaluated eight patients with IHCC associated with
IHDS (Table 5). Two patients who were evaluated by US
only were not preoperatively diagnosed with cholangio-
carcinoma. Four patients who had CT or ERCP in addition
to US were preoperatively diagnosed with cholangiocarci-
noma. During surgery, the correct diagnosis and exten-
sion of carcinoma was confirmed by intraoperative
examination of a frozen section.
Although liver resection could be performed in five
patients, three patients underwent curative resection
involving safe margins and lymph node dissection around
the hepatic hilum. In two of these patients, cholangiocar-
cinoma recurred within 4 months. One patient had a
recurrence in the remnant of the right medial section; in
the other patient, the cholangiocarcinoma recurred at
multiple sites in the peritoneal cavity. After a recurrence
was identified, the patients received conservative treat-
ment. The mean survival was 11.1 months. Only one
patient survived for 36 months without recurrence.
Discussion
Risk factors for IHCC include: IHDS,6 cystic liver disease,7
Clonorchis sinensis,8 primary biliary cirrhosis,9 ulcerative
colitis,10 Carolis disease,11 and congenital liver fibrosis.12
In Asia, IHDS is one of the factors that have been highly
associated with IHCC.13,14 Since Sanes and MacCallum2
reported two cases of cholangiocarcinoma related to
hepatolithiasis that were discovered incidentally at
autopsy for the first time in 1942, the association of IHDS
with IHCC has been reported to be from 4–11% in
reported series over the world.3,4,15–17 In our study, the
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Table 3. Classification of patients with intrahepatic duct stones by location
Location DS group CC group Total Incidence of cancer (%)*
Right only 17 1 18 6
Left only 44 7 51 14
Both 11 0 11 0
Total 72 8 80 10
*Incidence of cancer: proportion of CC group in total number. No significant difference in incidence by stone location (p = 0.082) by 
Chi-square test.
Table 4. Treatment methods used in the DS group (n=72)
Stone location Cases
Left IHDS patients (n=44)
LLS 24
Left hepatectomy 4
Hepatotomy 1
Choledochoscopic removal 10
Percutaneous drainage 1
No operation 4
Right IHDS patients (n=17)
Right hepatectomy 1
Choledochoscopic removal 12
No operation 4
Both IHDS patients (n=11)
LLS and choledochoscopic removal 2
Choledochoscopic removal 6
Choledochojejunostomy 1
No operation 2
IHDS = intrahepatic duct stone; LLS = left lateral sectionectomy.
proportion of patients who were diagnosed with IHCC
during the evaluations and treatment for IHDS was rela-
tively high at 10%.
The most important factors that contribute to stone
formation are bile stasis and bacterial infection in the bile
duct.18 Some investigators have described the association
between IHDS and IHCC to be due to mechanical injury
from intrahepatic calculi or chemical irritation to the bile
duct wall by infected bile.19 Other studies20,21 have reported
that recurrent cholangitis caused by IHDS results in the
development of atypical epithelium which may give rise
to cancerous lesions. In our study, we examined some liv-
ers with IHDS and those with IHCC that had atrophic
features.
Several reports in which the features of IHDS have
been described have shown that the most common 
presenting symptoms were associated with acute cholan-
gitis because a large portion of the liver with IHDS was
affected by stenosis in the bile duct.22,23 In some studies
comparing patients with only IHDS and those with IHDS
accompanied by IHCC,6,24,25 there were no significant dif-
ferences in clinical characteristics between these two
groups, but the features and locations of stones in addi-
tion to the levels of tumour markers have been shown to
be discriminating factors. In our study, there was no dif-
ference between the clinical features and characteristics
of stones evaluated in the DS and the CC groups.
With regard to radiologic evaluation, our results show
no difference in the frequency of usage of US, ERCP, CT.
Chen et al26 reported that a hyperechoic mass found in
the liver parenchyma by US should be considered to be an
IHCC. However, because the use of US is insufficient for
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Table 5. Clinical characteristics of the CC group
No
Age Clinical Radiologic Preoperative Postoperative CA 19-9 Surgical
Follow-up
Sex symptoms evaluation diagnosis diagnosis (U/mL) procedure
1 81 RUQ pain US Lt IHDS Lt IHDS Not T-tube ChT 16 months 
F Lt liver multiple checked and Bx died
IHCC 
2 37 RUQ pain US, CT, Lt IHDS Klatskin’s Not Bx 20 months 
F Fever ERCP with CCC tumour checked died 
Jaundice (type IV)
3 75 RUQ pain US GB CBD Lt IHDS 4438 T-tube ChT 18 months 
F Jaundice stone, Both liver and Bx died
Lt IHDS IHCC
4 70 RUQ pain CT Lt IHDS with Lt IHDS  2400 Palliative LH 5 months 
F Fever chronic Lt liver multiple died
cholangitis IHCC
5 61 RUQ pain US Lt IHD stone Lt IHDS  Not Curative LLS 36 months 
F Lt liver IHCC checked alive
6 59 RUQ pain US, CT, Lt IHDS Lt IHDS Not Palliative LH 5 months 
F Fever ERCP Lt liver IHCC Lt liver IHCC checked died
7 55 RUQ pain US,CT Lt IHDS Lt IHDS 5079 Curative LLS 2 months 
M Jaundice Lt liver IHCC Lt liver IHCC recurrence; 
6 months 
died
8 46 RUQ pain US,CT Rt IHDS Rt IHDS 460 Curative LH 4 months 
M Lt liver IHCC Lt liver IHCC recurrence; 
2 months 
died
RUQ = right upper quadrant; US = abdominal ultrasonography; IHDS = intrahepatic duct stone; IHCC = intrahepatic cholangiocarcinoma;
ChT = choledochostomy; Bx = biopsy; CT = computed tomography; ERCP = endoscopic retrograde cholangiopancreaticogram; LH = left
hepatectomy; LLS = left lateral sectionectomy.
the diagnosis of cholangiocarcinoma, percutaneous trans-
hepatic cholangiogram or endoscopic retrograde cholan-
giography should be considered for early diagnosis. Kubo
et al24 reported that portography can be used as an effec-
tive technique for the diagnosis of hepatic atrophy and
cholangiocarcinoma. Obstruction of the portal vein repre-
sents the deterioration of hepatic tissue and suggests the
presence of cholangiocarcinoma. Recent report presented
the helical CT scans was useful for diagnosis of cholan-
giocarcinoma in patients with hepatolithiasis using spe-
cific CT criteria including the periductal soft tissue
density, bile wall thickening, duct enhancement on portal
venous phase and lymph node enlargement.27 Therefore,
periodic CT scans after treatment of hepatolithiasis should
be performed in order to detect early the occurrence of
cholangiocarcinoma.
No specific tumour markers are available for the diag-
nosis of cholangiocarcinoma. However, an increase in the
level of CA 19-9 is more frequently encountered than other
tumour marker like carcinoembryonic antigen (CEA).28
Su et al29 reported that CA 19-9 levels were increased in
seven of nine patients with cholangiocarcinoma and
intrahepatic duct stones. We found a high level of CA 19-
9 in four patients in the CC group. However, because
some patients in the DS group had a level that was as high
as that of the patients who had the malignancy, and other
laboratory findings were not different between the two
groups, it is difficult to predict whether an accompanying
malignancy exists in patients having IHDS.
As a result, surgeons who treat patients with IHDS
using operative methods should examine carefully for
cancerous lesions. In the past, most surgeons who oper-
ated on patients diagnosed with IHDS would not con-
sider hepatic resection, since there was little knowledge
between IHCC and IHDS and hepatic resection was
regarded as a very risky procedure. Because of advance-
ments in hepatic surgery, liver resection has become an
option for the removal of IHDS to treat bile duct stric-
tures and hidden malignancy. Otani et al30 reported that
the recurrence rates of IHDS and cholangitis were signifi-
cantly reduced by hepatic resection, and another study
showed that hepatic resection for hepatolithiasis could be
performed safely with meticulous management of biliary
tract abnormalities.31,32 We performed a liver resection in
31 cases (43%) in the IHDS group; the most common
operation type was the left lateral sectionectomy. Based
on previously published reports,33,34 the indications for
hepatic resection included atrophy and fibrosis of a liver
segment, the possibility of concomitant IHCC, or
localised IHDS with biliary stricture. We performed liver
resections according to the above indications. Hepatic
resection, in our study, was performed in patients with left
IHDS more frequently than in patients with right IHDS.
Right liver resection was performed in only one patient
who had severe atrophic changes in the right lobe of the
liver; this was because of the high surgical risk of this pro-
cedure.35 Recently, however, the use of right hepatectomy
has been increasing for the treatment of selected patients
with isolated right-sided IHDS.36
In conclusion, our series showed there were no posi-
tive clinicopathologic or laboratory factors to predict
concomitant IHCC in IHDS patients. However, in several
patients, we could achieve curative resection of malignant
liver lesions. Therefore, surgeons performing operations
for IHDS patients should examine them thoroughly for
hidden malignancies. In addition, due to the possibility
of hidden malignant lesions, aggressive resection should
be performed in suspicious portions of the liver.
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